PAROTITIS WITH ORCHITIS IN ACUTE HCV- A RARE ASSOCIATION

Parveen Malhotra, Yogesh Sanwariya, Senti Senti, Jatin Kumar, Harman Singh, Sandeep KumarInternational Journal of Advanced Research 2024 · DOI

TL;DR

This paper presents a rare case of a 14-year-old male experiencing acute Hepatitis C Virus (HCV) infection, which manifested not only in the liver but also as bilateral parotid gland enlargement (parotitis) and testicular inflammation (orchitis). The findings highlight that HCV can have uncommon extrahepatic manifestations, emphasizing the need for clinicians to be vigilant for these symptoms in acute HCV cases.

What Problem Does This Paper Address?

While Hepatitis C Virus (HCV) is primarily known for its impact on the liver, it's increasingly recognized that HCV can affect various other organ systems, leading to a range of extrahepatic manifestations. These can include dermatological, neurological, renal, and autoimmune conditions. However, the specific association of acute HCV infection with parotitis and orchitis is exceptionally rare, with limited documented cases. This paper addresses the gap in understanding and awareness regarding these specific, uncommon presentations of acute HCV, aiming to alert healthcare professionals to their possibility.

Methods

This paper is a case report, which is a descriptive study of a single patient. The authors detail the clinical presentation, diagnostic workup, treatment, and follow-up of a 14-year-old male diagnosed with acute HCV infection. The diagnostic methods employed included:

  • Clinical Examination: Assessing symptoms like pain, swelling, nausea, and weakness.
  • Laboratory Tests: Measuring HCV RNA quantitative load, liver function tests (LFTs), renal function tests (RFTs), INR, thyroid function tests (T3, T4, TSH), blood sugar, and autoimmune profile.
  • Imaging: Ultrasound of the abdomen to assess liver and gallbladder status.
  • Fibroscan: To evaluate liver stiffness and rule out cirrhosis.
  • Polymerase Chain Reaction (PCR): To detect and quantify HCV RNA for diagnosis and monitoring treatment response (Sustained Virological Response - SVR).

The treatment involved a standard 12-week antiviral regimen for Hepatitis C.

Datasets

Not discussed in the paper. This is a case report focusing on a single patient's experience.

Key Insights and Ideas

  • Uncommon Extrahepatic Manifestations: The most striking insight is the co-occurrence of bilateral parotitis and orchitis in the context of acute HCV infection, a combination rarely reported.
  • HCV's Systemic Reach: This case reinforces that HCV is not solely a liver disease and can trigger inflammatory responses in diverse tissues, including salivary glands and testes.
  • Importance of Vigilance: The paper strongly advocates for increased clinical awareness. Healthcare providers should consider parotitis and orchitis as potential, albeit rare, extrahepatic signs of acute HCV infection.
  • Effective Antiviral Treatment: The case demonstrates the efficacy of modern antiviral therapy in not only clearing the HCV infection but also resolving these associated inflammatory symptoms.

Key Results

  • A 14-year-old male presented with acute HCV infection, characterized by a high HCV RNA quantitative load (765421 I.U./ml), hyperbilirubinemia, and transaminitis.
  • He developed bilateral painful enlargement of the parotid glands (parotitis) followed by bilateral painful orchitis.
  • Abdominal ultrasound showed mild hepatomegaly and gallbladder wall edema, consistent with acute hepatitis. Fibroscan indicated no evidence of cirrhosis.
  • Upon initiation of a 12-week antiviral treatment for HCV, both the parotitis and orchitis symptoms subsided within three weeks.
  • The patient achieved a Sustained Virological Response (SVR) after completing treatment, confirmed by the complete absence of HCV RNA on PCR.
  • After 1.5 years of follow-up, the patient remained healthy with no relapse of HCV infection or the parotitis/orchitis symptoms.

Limitations and Future Work

  • Single Case Report: The primary limitation is that this is a report of a single case. Generalizing these findings to the broader HCV-infected population requires further investigation.
  • Paucity of Data: The authors explicitly mention the scarcity of data on parotitis and orchitis in acute HCV infections, highlighting the need for more research in this area.
  • Future Work: The authors suggest that targeted diagnostic protocols may help in identifying parotid involvement among HCV-infected individuals. Future research should focus on understanding the underlying mechanisms of these rare extrahepatic manifestations and their prevalence in larger cohorts. Further studies could also explore whether these symptoms are more common with specific HCV genotypes or in certain patient demographics.

Summary updated

Abstract

Case report:A male of fourteen years, having non-significant past history, was detected to be sufferingfrom acute hepatitis C virus (HCV) infection, presented with acuteonset of gradually progressive bilateral painful enlargement of parotid glands which was followed by bilateral painful orchitis. His HCV RNA quantitative load was 765421 I.U./ml with hyperbilirubinemia and transaminitis.The ultrasound abdomen revealed mild hepatomegaly with gall bladder wall oedema suggestive of acute hepatitis. He had no evidence of cirrhosis as evidenced by normal Fibroscan score of 6.5. At the time of first consultation, his mental status was normal without any fever but was having mild nausea and generalized weakness. His bilateral parotid glands were enlarged and painful for last one week. He also developed bilateral painful orchitis after five days of developing parotitis. He was started on antiviral treatment for hepatitis C for total of 12 weeks duration but his bilateral parotitis and orchitis subsided within three weeks of starting of treatment. He completed his 12 weeks antiviral treatment and later on achieved 12 weeks sustained virological response (SVR), as evidenced by complete absence of HCV RNA on polymerase chain testing (PCR) report. He has been followed for one and half year and repeat HCV RNA test and clinical examination for relapse is non-contributory. Conclusion:Our case reportis an uncommon extrahepatic manifestation of acute HCV case of bilateral parotitis in an acute hepatitis C patient. There is paucity of data regardingparotitis and orchitis with acute hepatitis C infection, hence merits vigil for the same by the treating health care specialist.
BibTeX
@article{malhotra2024parotitis,
  author = {Parveen Malhotra and Yogesh Sanwariya and Senti Senti and Jatin Kumar and Harman Singh and Sandeep Kumar},
  title = {{PAROTITIS WITH ORCHITIS IN ACUTE HCV- A RARE ASSOCIATION}},
  journal = {International Journal of Advanced Research},
  year = {2024},
  doi = {10.21474/ijar01/20088},
}
Figure